153 related articles for article (PubMed ID: 35667416)
1. ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy.
Deng M; Kutrolli E; Sadewasser A; Michel S; Joibari MM; Jaschinski F; Olivecrona G; Nilsson SK; Kersten S
J Lipid Res; 2022 Jul; 63(7):100237. PubMed ID: 35667416
[TBL] [Abstract][Full Text] [Related]
2. Chronic high-fat feeding and prolonged fasting in liver-specific ANGPTL4 knockout mice.
Spitler KM; Shetty SK; Cushing EM; Sylvers-Davie KL; Davies BSJ
Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E464-E478. PubMed ID: 34396783
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ANGPTL4 function in macrophages and adipocytes using
Oteng AB; Ruppert PMM; Boutens L; Dijk W; van Dierendonck XAMH; Olivecrona G; Stienstra R; Kersten S
J Lipid Res; 2019 Oct; 60(10):1741-1754. PubMed ID: 31409739
[TBL] [Abstract][Full Text] [Related]
4. Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice.
Spitler KM; Shetty SK; Cushing EM; Sylvers-Davie KL; Davies BSJ
Sci Rep; 2021 Apr; 11(1):7873. PubMed ID: 33846453
[TBL] [Abstract][Full Text] [Related]
5. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism.
Kersten S
J Lipid Res; 2021; 62():100150. PubMed ID: 34801488
[TBL] [Abstract][Full Text] [Related]
6. Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis.
Aryal B; Singh AK; Zhang X; Varela L; Rotllan N; Goedeke L; Chaube B; Camporez JP; Vatner DF; Horvath TL; Shulman GI; Suárez Y; Fernández-Hernando C
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563332
[TBL] [Abstract][Full Text] [Related]
7. Characterization of sexual dimorphism in ANGPTL4 levels and function.
Deng M; Kersten S
J Lipid Res; 2024 Apr; 65(4):100526. PubMed ID: 38431115
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting.
Cushing EM; Chi X; Sylvers KL; Shetty SK; Potthoff MJ; Davies BSJ
Mol Metab; 2017 Aug; 6(8):809-818. PubMed ID: 28752045
[TBL] [Abstract][Full Text] [Related]
9. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake.
Lichtenstein L; Berbée JF; van Dijk SJ; van Dijk KW; Bensadoun A; Kema IP; Voshol PJ; Müller M; Rensen PC; Kersten S
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2420-7. PubMed ID: 17761937
[TBL] [Abstract][Full Text] [Related]
10. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
Janssen AWF; Katiraei S; Bartosinska B; Eberhard D; Willems van Dijk K; Kersten S
Diabetologia; 2018 Jun; 61(6):1447-1458. PubMed ID: 29502266
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
[TBL] [Abstract][Full Text] [Related]
12. Novel GPIHBP1-independent pathway for clearance of plasma TGs in
Cushing EM; Sylvers KL; Chi X; Shetty SK; Davies BSJ
J Lipid Res; 2018 Jul; 59(7):1230-1243. PubMed ID: 29739862
[TBL] [Abstract][Full Text] [Related]
13. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.
Gordts PL; Nock R; Son NH; Ramms B; Lew I; Gonzales JC; Thacker BE; Basu D; Lee RG; Mullick AE; Graham MJ; Goldberg IJ; Crooke RM; Witztum JL; Esko JD
J Clin Invest; 2016 Aug; 126(8):2855-66. PubMed ID: 27400128
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide treatment produces a type I interferon response that protects against diet-induced obesity.
McCabe KM; Hsieh J; Thomas DG; Molusky MM; Tascau L; Feranil JB; Qiang L; Ferrante AW; Tall AR
Mol Metab; 2020 Apr; 34():146-156. PubMed ID: 32180554
[TBL] [Abstract][Full Text] [Related]
15. A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
Fowler A; Sampson M; Remaley AT; Chackerian B
Vaccine; 2021 Sep; 39(40):5780-5786. PubMed ID: 34474934
[TBL] [Abstract][Full Text] [Related]
16. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice.
Wang Y; Liu LM; Wei L; Ye WW; Meng XY; Chen F; Xiao Q; Chen JY; Zhou Y
Mol Med Rep; 2016 Oct; 14(4):3293-300. PubMed ID: 27573470
[TBL] [Abstract][Full Text] [Related]
18. Effect of diet-induced weight loss on angiopoietin-like protein 4 and adipose tissue lipid metabolism in overweight and obese humans.
van der Kolk BW; Vink RG; Jocken JWE; Roumans NJT; Goossens GH; Mariman ECM; van Baak MA; Blaak EE
Physiol Rep; 2018 Jul; 6(13):e13735. PubMed ID: 29998530
[TBL] [Abstract][Full Text] [Related]
19. Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue.
Dijk W; Schutte S; Aarts EO; Janssen IMC; Afman L; Kersten S
J Clin Lipidol; 2018; 12(3):773-783. PubMed ID: 29555209
[TBL] [Abstract][Full Text] [Related]
20. Feeding
Oteng AB; Bhattacharya A; Brodesser S; Qi L; Tan NS; Kersten S
J Lipid Res; 2017 Jun; 58(6):1100-1113. PubMed ID: 28412693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
